Grantham, Mayo, Van Otterloo & Co (GMO)’s Vertiv VRT Stock Holding History
Bought
Maintained
Sold
Other funds holding VRT
Grantham, Mayo, Van Otterloo & Co (GMO)'s VRT Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Vertiv (VRT) stake by 12% in Q2 2026, selling an estimated $252K and leaving 5,953 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #439.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in VRT in Q1 2021 and has held it in 3 quarters since. 2,052 funds tracked by Wall St. Rank hold VRT as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 5,953 shares of Vertiv worth $1.99M as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 795 Vertiv shares in Q2 2026, an estimated $252K.
- Vertiv made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #439 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Vertiv in Q1 2021 and has held it in 3 quarters since.
- 2,052 funds tracked by Wall St. Rank held Vertiv as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.